Understanding melatonin receptor pharmacology: Latest insights from mouse models, and their relevance to human disease
Citations Over TimeTop 10% of 2014 papers
Abstract
Melatonin, the neuro-hormone synthesized during the night, has recently seen an unexpected extension of its functional implications toward type 2 diabetes development, visual functions, sleep disturbances, and depression. Transgenic mouse models were instrumental for the establishment of the link between melatonin and these major human diseases. Most of the actions of melatonin are mediated by two types of G protein-coupled receptors, named MT1 and MT2 , which are expressed in many different organs and tissues. Understanding the pharmacology and function of mouse MT1 and MT2 receptors, including MT1 /MT2 heteromers, will be of crucial importance to evaluate the relevance of these mouse models for future therapeutic developments. This review will critically discuss these aspects, and give some perspectives including the generation of new mouse models.
Related Papers
- → Melatonin receptor structures shed new light on melatonin research(2019)59 cited
- → Melatonin-mediated regulation of human MT1 melatonin receptors expressed in mammalian cells(2004)79 cited
- → Expression of melatonin receptor (MT1) and interaction between melatonin and estrogen in endometrial cancer cell line(2008)21 cited
- → Melatonin Regulates the mRNA Expression of the mt<sub>1</sub> Melatonin Receptor in the Rat Pars tuberalis(2000)47 cited
- → Melatonin receptor genes(1998)26 cited